GlassScriptPhysician profile
Esther Yaniv
NPI 1245240712
$831.87
in general payments reported to CMS, 2019-2025
9 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2022: $33.71 · 2023: $15.36 · 2024: $380 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $351.33 | 2024 | Synchromedii |
| Spinal Simplicity, LLC | $154.93 | 2025 | Ha Minuteman G3-R |
| Nevro Corp. | $111.11 | 2019 | |
| Boston Scientific Corporation | $95.74 | 2025 | General - Pain Management |
| Stryker Corporation | $40.88 | 2025 | Alphavent |
| Axogen | $28.81 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Endo Pharmaceuticals INC. | $20.21 | 2022 | |
| Bioventus LLC | $15.36 | 2023 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Yaniv listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.